Question 1

What is C2N Diagnostics?

Accepted Answer

C2N Diagnostics is a Entity.

Question 2

How often does C2N Diagnostics appear in global news?

Accepted Answer

Tracked across 5 news events drawn from 532 articles.

Question 3

When was C2N Diagnostics first tracked by Ergen?

Accepted Answer

First tracked on Feb 19, 2026.

Question 4

When was C2N Diagnostics last mentioned in news?

Accepted Answer

Last active on Aug 11, 2026.

Question 5

What is C2N Diagnostics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 36 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is C2N Diagnostics in global news coverage?

Accepted Answer

Attention score of 8, derived from article volume and coverage intensity across 5 events.

Question 7

What is the most recent event involving C2N Diagnostics?

Accepted Answer

CNSide Diagnostics receives CAP accreditation (Jun 04, 2026, 7 articles).

Question 8

How did the "CNSide Diagnostics receives CAP accreditation" event impact C2N Diagnostics?

Accepted Answer

C2N Diagnostics received CAP accreditation, which validates its laboratory quality and is expected to support commercial expansion, broader payer coverage, and health system adoption for its CNSide CSF Assay Platform.

Question 9

How did the "Blood Test Predicts Alzheimer's Onset" event impact C2N Diagnostics?

Accepted Answer

C2N Diagnostics developed PrecivityAD2, a clinically available Alzheimer's blood test used in the study, and is a startup co-founded by Washington University in St. Louis researchers.

Question 10

How did the "Axtria Ignite 2026 Conference" event impact C2N Diagnostics?

Accepted Answer

C2N Diagnostics was honored with the Axtria Bedrock Honor for a 15-year partnership with Axtria and the successful implementation of Axtria SalesIQ, demonstrating a complex sales force alignment solution.

Question 11

How did the "Unknown Event" event impact C2N Diagnostics?

Accepted Answer

C2N Diagnostics' RealStar Filovirus Screen RT-PCR Kit 1.0 is being used to detect the Bundibugyo outbreak in the Democratic Republic of the Congo, and the firm has ramped up production.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.